Home Mf Research Hdfc Pharma And Healthcare Fund Regular Plan Growth
HDFC Mutual Fund

HDFC Pharma and Healthcare Fund - Regular Plan - Growth

Equity Equity Sectoral Thematic
Fund House : HDFC Mutual Fund
Overview
Returns
Portfolio
Analysis
Peer Comparison
Fund Family
Scheme Details
-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • SI
NAV (as on 2025-06-23)
16.33 -0.06%
Fund Size (Total Assets)
-
Expense Ratio (Regular)
2.24%
Expense Ratio (Direct)
1.01%
SIP Returns
Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-06-16 ₹1,000.00 ₹973.53
-2.65 %
Two Week 2025-06-09 ₹1,000.00 ₹993.61
-0.64 %
One Month 2025-05-26 ₹1,000.00 ₹1,005.23
0.52 %
Three Months 2025-03-25 ₹3,000.00 ₹3,021.33
0.71 %
Six Months 2024-12-26 ₹6,000.00 ₹6,186.73
3.11 %
One Year 2024-06-24 ₹12,000.00 ₹12,667.44
5.56 %
Since Inception 2023-10-04 ₹21,000.00 ₹25,423.71
21.07 %
Portfolio Summary
Company Name Sector Sector Type Nav(in %)
Sun Pharmaceutical Industries Ltd. Pharmaceuticals & Biotechnology Equity 12.25
Divis Laboratories Ltd. Pharmaceuticals & Biotechnology Equity 10.24
Cipla Ltd. Pharmaceuticals & Biotechnology Equity 7.00
Lupin Ltd. Pharmaceuticals & Biotechnology Equity 5.59
Max Healthcare Institute Limited Healthcare Services Equity 4.83
Glenmark Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology Equity 4.12
Ipca Laboratories Ltd. Pharmaceuticals & Biotechnology Equity 3.99
Krishna Institute Of Medical Sciences Limited Healthcare Services Equity 3.95
Aster DM Healthcare Limited Healthcare Services Equity 3.92
Eris Lifesciences Ltd Pharmaceuticals & Biotechnology Equity 3.54
Torrent Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology Equity 3.42
Aurobindo Pharma Ltd. Pharmaceuticals & Biotechnology Equity 3.11
Wockhardt Ltd. Pharmaceuticals & Biotechnology Equity 2.95
Gland Pharma Ltd. Pharmaceuticals & Biotechnology Equity 2.75
Alkem Laboratories Ltd. Pharmaceuticals & Biotechnology Equity 2.63
Metropolis Healthcare Ltd. Healthcare Services Equity 2.42
Vijaya Diagnostic Centre Limited Healthcare Services Equity 2.39
Acutaas Chemicals Limited Pharmaceuticals & Biotechnology Equity 2.20
Piramal Pharma Limited Pharmaceuticals & Biotechnology Equity 2.12
Cohance Lifesciences Limited Pharmaceuticals & Biotechnology Equity 1.95
Dr. Lal Path Labs Ltd Healthcare Services Equity 1.78
Jubilant Pharmova Limited Pharmaceuticals & Biotechnology Equity 1.78
Fortis Healthcare Limited Healthcare Services Equity 1.62
Pfizer Ltd. Pharmaceuticals & Biotechnology Equity 1.62
Laxmi Dental Limited Healthcare Equipment & Supplies Equity 1.45
BAJAJ HEALTHCARE LIMITED - Prefential Issue Pharmaceuticals & Biotechnology Equity 1.25
Sai Life Sciences Limited Pharmaceuticals & Biotechnology Equity 1.13
Medi Assist Healthcare Services Limited Insurance Equity 1.08
Zydus Lifesciences Limited Pharmaceuticals & Biotechnology Equity 1.08
Ajanta Pharma Limited Pharmaceuticals & Biotechnology Equity 0.70
BAJAJ HEALTHCARE LIMITED Pharmaceuticals & Biotechnology Equity 0.35
TREPS - Tri-party Repo - Debt 1.08
Net Current Assets - - -0.29
Risk Ratios
Standard Deviation
14.882
Beta
0.753
Sharpe Ratio
3.264
Lock In Period
-
Residual Maturity
-
Standard Deviation:
Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.
Beta:
Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.
Sharpe Ratio:
The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.
Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.
Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.
Scheme Details
  • Fund manager(s) : Nikhil Mathur (Over 14 years), Dhruv Muchhal (Over 10 years),
  • Expense ration regular : 2.24
  • Expense ration direct : 1.01
  • Launch date : -
  • Benchmark : -
  • Min SIP amount : -
  • Max SIP amount : -
  • Min investment amount (one time- first time) : ₹100.00
  • Type : equity
Exit load
1% within 30 days from the date of allotment.

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?